Vital ResearchVITAL RESEARCH
Product Usage

All products made available on this website are intended exclusively for research and development purposes and are strictly not for human consumption or therapeutic use. These products are not approved by the U.S. Food and Drug Administration (FDA), and no statements on this website have been evaluated by the FDA.

BPC-157 10mg
Tissue Research

BPC-15710mg

BPC-157 peptide for soft-tissue and angiogenesis-model research.

Lyophilized powderSKU VR-BPC157Available now
$65per vial
Product handling note

Lyophilized powder may shift or come loose during transit; that is a normal occurrence and does not affect the integrity of the research product. Fill appearance and batch-specific details may vary. Refer to the Certificate of Analysis below for the documentation tied to the current batch.

Research overview

Why researchers study BPC-157 by itself.

BPC-157 is usually discussed as its own soft-tissue research lane rather than only as part of a blend. The literature is mostly preclinical and centers on model systems involving tissue structure, angiogenesis signaling, tendon or ligament context, and cellular response after controlled stress.

The clean product-page distinction is simple: BPC-157 by itself gives researchers the single-component material, while VR-BPC-TB and Glow are blend comparisons with additional thymosin beta-4-style or copper-peptide lanes.

What you get with every vial.

COA

Certificate of Analysis

Third-party HPLC and MS testing for every batch, published before purchase and tied to the batch being sold.

HPLC / MS
ID

Batch traceability

Every vial is stamped with a batch ID that links back to its COA, source record, and current product documentation.

Batch linked
Label

Batch-linked labeling

Product identity, strength, and batch reference stay easy to match from the product listing to the vial in hand.

Listing to vial
Product FAQ

Common research questions.

Why offer BPC-157 separately from the BPC/TB blend?

A single-component listing is cleaner when the research question is specifically about BPC-157. The blend is more useful when the question is about adjacent BPC-157 and thymosin beta-4-style lanes together.

What kind of literature is most relevant here?

The useful source trail is mostly preclinical: soft-tissue models, angiogenesis signaling, tendon or ligament context, and tissue-structure response. It should not be read as human-use guidance.

What should the batch documentation confirm?

It should connect the vial code, identity test, purity result, strength, and COA to the exact BPC-157 batch being shipped.

How is this different from Glow?

Glow adds GHK-Cu and a TB-500-style peptide. BPC-157 is the narrower single-component lane.

Research sources

Literature links are included for background reading. Batch-specific identity and purity details live in the COA tied to the current batch.

BPC-157$65